Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 1
1982 2
1984 1
1985 2
1987 2
1988 3
1989 1
1991 1
1992 1
1993 1
1995 1
1999 1
2001 1
2002 1
2007 1
2008 1
2009 1
2012 1
2013 2
2014 2
2015 2
2016 1
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
Exploring the potential of adjunct therapy in tuberculosis.
Rayasam GV, Balganesh TS. Rayasam GV, et al. Among authors: balganesh ts. Trends Pharmacol Sci. 2015 Aug;36(8):506-13. doi: 10.1016/j.tips.2015.05.005. Epub 2015 Jun 11. Trends Pharmacol Sci. 2015. PMID: 26073420 Review.
Biomedicine and biotechnology: public health impact.
Ganguly NK, Croft S, Singh L, Sinha S, Balganesh T. Ganguly NK, et al. Among authors: balganesh t. Biomed Res Int. 2014;2014:524785. doi: 10.1155/2014/524785. Epub 2014 Apr 8. Biomed Res Int. 2014. PMID: 24809051 Free PMC article. No abstract available.
Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity.
Landge S, Ramachandran V, Kumar A, Neres J, Murugan K, Sadler C, Fellows MD, Humnabadkar V, Vachaspati P, Raichurkar A, Sharma S, Ravishankar S, Guptha S, Sambandamurthy VK, Balganesh TS, Ugarkar BG, Balasubramanian V, Bandodkar BS, Panda M. Landge S, et al. Among authors: balganesh ts. ChemMedChem. 2016 Feb 4;11(3):331-9. doi: 10.1002/cmdc.201500462. Epub 2016 Jan 11. ChemMedChem. 2016. PMID: 26751718
Rising standards for tuberculosis drug development.
Balganesh TS, Alzari PM, Cole ST. Balganesh TS, et al. Trends Pharmacol Sci. 2008 Nov;29(11):576-81. doi: 10.1016/j.tips.2008.08.001. Epub 2008 Sep 15. Trends Pharmacol Sci. 2008. PMID: 18799223 Review.
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.
Makarov V, Manina G, Mikusova K, Möllmann U, Ryabova O, Saint-Joanis B, Dhar N, Pasca MR, Buroni S, Lucarelli AP, Milano A, De Rossi E, Belanova M, Bobovska A, Dianiskova P, Kordulakova J, Sala C, Fullam E, Schneider P, McKinney JD, Brodin P, Christophe T, Waddell S, Butcher P, Albrethsen J, Rosenkrands I, Brosch R, Nandi V, Bharath S, Gaonkar S, Shandil RK, Balasubramanian V, Balganesh T, Tyagi S, Grosset J, Riccardi G, Cole ST. Makarov V, et al. Among authors: balganesh t. Science. 2009 May 8;324(5928):801-4. doi: 10.1126/science.1171583. Epub 2009 Mar 19. Science. 2009. PMID: 19299584 Free PMC article.
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.
Padmapriyadarsini C, Bhavani PK, Natrajan M, Ponnuraja C, Kumar H, Gomathy SN, Guleria R, Jawahar SM, Singh M, Balganesh T, Swaminathan S. Padmapriyadarsini C, et al. Among authors: balganesh t. BMJ Open. 2019 Mar 1;9(3):e024363. doi: 10.1136/bmjopen-2018-024363. BMJ Open. 2019. PMID: 30826761 Free PMC article.
Aminopyrazinamides: novel and specific GyrB inhibitors that kill replicating and nonreplicating Mycobacterium tuberculosis.
Shirude PS, Madhavapeddi P, Tucker JA, Murugan K, Patil V, Basavarajappa H, Raichurkar AV, Humnabadkar V, Hussein S, Sharma S, Ramya VK, Narayan CB, Balganesh TS, Sambandamurthy VK. Shirude PS, et al. Among authors: balganesh ts. ACS Chem Biol. 2013 Mar 15;8(3):519-23. doi: 10.1021/cb300510w. Epub 2012 Dec 31. ACS Chem Biol. 2013. PMID: 23268609
32 results